Gate Bioscience
PrivateLast Round
Series B
Nov 13, 2025
Est. Valuation
$161M
Total Funding Raised
$135M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Gate Bioscience is a biotechnology company that develops small molecule drugs known as Molecular Gates to selectively eliminate disease-causing extracellular proteins at their source within cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gate Bioscience Comparables
Compare Gate Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Magnet Biomedicine | 81% | |
| Plexium | 80% | |
| Proxygen | 78% |
Gate Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 13, 2025 | ||||
| Series A | Nov 1, 2023 |
Key People
Founding team and executive leadership
Gate Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed, Series B, Series A |
| GV | Series A, Series B |
| Forbion | Series B |
| ARCH Venture Partners | Series A, Series B |
| ARCH Venture Partners | Series A, Series B |
| Versant Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 36% MoM, reaching 2.3K.
- Jul 25, 2026
Monthly visitors increased 36% MoM to 1.7K.
Gate Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Gate Bioscience's valuation, stock price, and market status.
Is Gate Bioscience a public or private company?
Gate Bioscience is a private company.
What is the current stock price of Gate Bioscience?
Gate Bioscience is a private company with no public stock price. No recent secondary market data is available.
How much is Gate Bioscience worth (valuation)?
Valuation information for Gate Bioscience is not publicly available.
Can I buy Gate Bioscience stock?
Gate Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Gate Bioscience's last funding round?
Gate Bioscience's most recent funding round was Series B on November 13, 2025.
Who are the main investors in Gate Bioscience?
Key investors in Gate Bioscience include Andreessen Horowitz, Forbion, Versant Ventures.
Will Gate Bioscience IPO soon?
No public IPO plans have been announced for Gate Bioscience.
How can I track Gate Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gate Bioscience's secondary market activity and sign up for updates.